44
Views
0
CrossRef citations to date
0
Altmetric
Research Article

PROpwr: a Shiny R application to analyze patient-reported outcomes data and estimate power

, , , , , & show all
Received 28 Dec 2022, Accepted 05 Jun 2024, Published online: 13 Jun 2024

References

  • Bagheri, Z., S. M. Ayatollahi, and P. Jafari. 2011, December. Comparison of three tests of homogeneity of odds ratios in multicenter trials with unequal sample sizes within and among centers. BMC Medical Research Methodology 11 (1):1–8. doi:10.1186/1471-2288-11-58.
  • Bjorner, J. B., M. A. Petersen, M. Groenvold, N. Aaronson, M. Ahlner-Elmqvist, J. I. Arraras, A. Brédart, P. Fayers, M. Jordhoy, M. Sprangers, et al. 2004, December. Use of item response theory to develop a shortened version of the EORTC QLQ-C30 emotional functioning scale. Quality of Life Research 13 :1683–1697. doi:10.1007/s11136-004-7866-x.
  • Blanchin, M., J. B. Hardouin, F. Guillemin, B. Falissard, V. Sébille, and M. Gasparini. 2013, February 28. Power and sample size determination for the group comparison of patient-reported outcomes with rasch family models. PLoS ONE 8 (2):e57279. doi:10.1371/journal.pone.0057279.
  • Brundage, M., J. Blazeby, D. Revicki, B. Bass, H. De Vet, H. Duffy, F. Efficace, M. King, C. L. Lam, D. Moher, et al. 2013, August. Patient-reported outcomes in randomized clinical trials: Development of ISOQOL reporting standards. Quality of Life Research 22 (6):1161–1175. doi:10.1007/s11136-012-0252-1.
  • Bushmakin, A. G., and J. C. Cappelleri. 2022. A practical approach to quantitative validation of patient-reported outcomes: a simulation-based guide using SAS. Hoboken, NJ: John Wiley & Sons
  • Calvert, M., D. Kyte, R. Mercieca-Bebber, A. Slade, A. W. Chan, M. T. King, A. Hunn, A. Bottomley, A. Regnault, C. Ells, et al. 2018, February 6. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: The SPIRIT-PRO extension. JAMA 319 (5):483–494. doi:10.1001/jama.2017.21903.
  • Cappelleri, J. C., K. H. Zou, A. G. Bushmakin, J. M. J. Alvir, D. Alemayehu, and T. Symonds. 2013. Patient-reported outcomes: measurement, implementation and interpretation. Chapman & Hall/CRC Press, Boca Raton, FL.
  • Carpenter, B., A. Gelman, M. D. Hoffman, D. Lee, B. Goodrich, M. Betancourt, M. A. Brubaker, J. Guo, P. Li, and A. Riddell. 2017. Stan: A probabilistic programming language. Journal of Statistical Software 76 (1). doi:10.18637/jss.v076.i01.
  • Cohen, J. 2013, September 3. Statistical power analysis for the behavioral sciences. New York: Academic press.
  • Debelak, R., and I. Koller. 2020, March. Testing the local independence assumption of the rasch model with Q 3-based nonparametric model tests. Applied Psychological Measurement 44 (2):103–117. doi:10.1177/0146621619835501.
  • Deshpande, P. R., S. Rajan, B. L. Sudeepthi, and C. A. Nazir. 2011, October. Patient-reported outcomes: A new era in clinical research. Perspectives in Clinical Research 2 (4):137. doi:10.4103/2229-3485.86879.
  • Doostfatemeh, M., S. M. Ayatollah, and P. Jafari. 2016, Jul 1. Power and sample size calculations in clinical trials with patient-reported outcomes under equal and unequal group sizes based on graded response model: A simulation study. Value in Health 19 (5):639–647. doi:10.1016/j.jval.2016.03.1857.
  • Embretson, S. E., and S. P. Reise. 2000. Item response theory for psychologists. Mahwah, NJ: Lawrence Erlbaum Associates Publishers.
  • Embretson, S. E., and S. P. Reise. 2013, September 5. Item response theory. Mahwah, New Jersey: Psychology Press.
  • European Medicines Agency. 2016. Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man. https://www.ema.europa.eu/en/documents/other/appendix-2-guideline-evaluation-anticancer-medicinal-products-man_en.pdf.
  • Fitzpatrick, R., J. M. Norquist, C. Jenkinson, B. C. Reeves, R. W. Morris, D. W. Murray, and P. J. Gregg. 2004, March. A comparison of Rasch with Likert scoring to discriminate between patients’ evaluations of total hip replacement surgery. Quality of Life Research 13 (2):331–338. doi:10.1023/B:QURE.0000018489.25151.e1.
  • Food and Drug Administration. 2009. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. https://www.fda.gov/media/77832/download.
  • Fox, JP. 2010. Bayesian item response modeling: Theory and applications. New York: Springer.
  • Frost, M. H., B. B. Reeve, A. M. Liepa, J. W. Stauffer, R. D. Hays, and Mayo/FDA Patient‐Reported Outcomes Consensus Meeting Group. 2007, November. What is sufficient evidence for the reliability and validity of patient‐reported outcome measures? Value in Health 10:S94–105. doi:10.1111/j.1524-4733.2007.00272.x.
  • Gelman, A., J. B. Carlin, H. S. Stern, and D. R. Rubin. 2003. Bayesian data analysis, 2nd ed. Boca Raton, FL: Chapman & Hall.
  • Gelman, A., and D. B. Rubin. 1992, November. Inference from iterative simulation using multiple sequences. Statistical Science 7 (4):457–472. doi:10.1214/ss/1177011136.
  • Gotay, C. C., J. Lipscomb, and C. F. Snyder. 2005, November 2. Reflections on findings of the cancer outcomes measurement working group: Moving to the next phase. JNCI Journal of the National Cancer Institute 97 (21):1568–1574. doi:10.1093/jnci/dji337.
  • Guilleux, A., M. Blanchin, J. B. Hardouin, V. Sébille, and R. J. van Beers. 2014, January 10. Power and sample size determination in the Rasch model: Evaluation of the robustness of a numerical method to non-normality of the latent trait. PLoS ONE 9 (1):e83652. doi:10.1371/journal.pone.0083652.
  • Hardouin, J. B., S. Amri, M. L. Feddag, and V. Sébille. 2012, May 20. Towards power and sample size calculations for the comparison of two groups of patients with item response theory models. Statistics in Medicine 31 (11–12):1277–1290. doi:10.1002/sim.4387.
  • Holman, R., C. A. Glas, and R. J. de Haan. 2003, August 1. Power analysis in randomized clinical trials based on item response theory. Controlled clinical trials 24 (4):390–410. doi:10.1016/S0197-2456(03)00061-8.
  • Hu, J., J. Thompson, D. P. Mudaranthakam, L. C. Hinton, D. Streeter, M. Park, B. Terluin, and B. Gajewski. 2022, January 1. Estimating power for clinical trials with patient reported outcomes-using item response theory. Journal of Clinical Epidemiology 141:141–148. doi:10.1016/j.jclinepi.2021.10.002.
  • Jafari, P., S. M. Ayatollahi, and J. Behboodian. 2006 December. Sequential boundaries approach in clinical trials with unequal allocation ratios. BMC Medical Research Methodology 6 (1):1–8. doi:10.1186/1471-2288-6-1.
  • Johnson, M. S. 2007, February 22. Marginal maximum likelihood estimation of item response models in R. Journal of Statistical Software 20 (10):1–24. doi:10.18637/jss.v020.i10.
  • Julious, S. A., S. George, D. Machin, and R. J. Stephens. 1997, March. Sample sizes for randomized trials measuring quality of life in cancer patients. Quality of Life Research 6 (2):109–117. doi:10.1023/A:1026481815304.
  • Nydick, S. 2022. R package version 0.5.1. catIrt: Simulate IRT-Based computerized adaptive tests. https://CRAN.R-project.org/package=catIrt.
  • R Core Team. 2022. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. https://www.R-project.org/.
  • Reeve, B. B., R. D. Hays, C. H. Chang, and E. M. Perfetto. 2007, August. Applying item response theory to enhance health outcomes assessment. Quality of Life Research 16 (S1):1–3. doi:10.1007/s11136-007-9220-6.
  • Rizopoulos, D. 2007. ltm an R package for latent variable modeling and item response theory analyses. Journal of Statistical Software 17 (5):1–25. doi:10.18637/jss.v017.i05.
  • Rp, C. 2012, May 24. mirt: A multidimensional item response theory package for the R environment. Journal of Statistical Software 48 (6):1–29. doi:10.18637/jss.v048.i06.
  • Samejima, F. 1969. Estimation of latent ability using a response pattern of graded scores. Psychometrika Monograph Supplement 34 (S1):1–97. doi:10.1007/BF03372160.
  • Sébille, V., J. B. Hardouin, L. Néel T, G. Kubis, F. Boyer, F. Guillemin, and B. Falissard. 2010 December. Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients-a simulation study. BMC Medical Research Methodology 10 (1):1–0. doi:10.1186/1471-2288-10-24.
  • Stan Development Team. 2020. R package version 2.21.2. RStan: The R interface to Stan. http://mc-stan.org/.
  • Tunis, S. R., D. B. Stryer, and C. M. Clancy. 2003, September 24. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. Jama 290 (12):1624–1632. doi:10.1001/jama.290.12.1624.
  • Van der Linden WJ, and Hambleton RK, eds. 2013. Item response theory: brief history, common models, and extensions. Handbook of modern item response theory. Ann Arbor, Michigan: Springer Science & Business Media, March 9.
  • Vehtari, A., A. Gelman, D. Simpson, B. Carpenter, and P. C. Bürkner. 2021 Jun. Rank-normalization, folding, and localization: An improved R ̂ for assessing convergence of MCMC (with discussion). Bayesian Analysis 16 (2):667–718. doi:10.1214/20-BA1221.
  • Walters, S. J. 2009, October 26. Quality of life outcomes in clinical trials and health-care evaluation: a practical guide to analysis and interpretation. Chichester, (UK): John Wiley & Sons, Ltd.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.